文献速递头颈CT

双能CT鉴别T1期鼻咽癌与淋巴组织增生

Dual-energy CT in the differentiation of stage T1 nasopharyngeal carcinoma and lymphoid hyperplasia.
PubMed 文献 · Eur J Radiol · 2020-01-09

回顾性纳入病理证实的T1期鼻咽癌30例和淋巴组织增生47例,测量双能CT定量参数。T1期鼻咽癌的碘浓度、标准化碘浓度、有效原子序数、50-110 keV虚拟单能图像及能谱曲线斜率均显著高于淋巴组织增生,70 keV单参数AUC最高为0.92,多参数联合AUC达0.99。结论认为双能CT有助于两者鉴别。

要点

  • T1期鼻咽癌的碘浓度、标准化碘浓度及有效原子序数均显著高于淋巴组织增生(p<0.001)。
  • 70 keV虚拟单能图像鉴别两者AUC最高(0.92),敏感度80.00%、特异度91.49%。
  • 多参数联合模型AUC达0.99,敏感度93.33%、特异度97.87%。

关键影像表现/征象

  • T1期鼻咽癌的碘浓度和标准化碘浓度(以颈内静脉为参考)均显著高于淋巴组织增生(p<0.001)。
  • T1期鼻咽癌的有效原子序数显著高于淋巴组织增生(p<0.001)。
  • T1期鼻咽癌在50 keV-110 keV(间隔20 keV)的虚拟单能图像CT值均显著高于淋巴组织增生(均p<0.001)。
  • T1期鼻咽癌的能谱衰减曲线斜率k值显著高于淋巴组织增生(p<0.001)。
  • 虚拟平扫及130 keV-190 keV(间隔20 keV)虚拟单能图像在两组间无显著差异。

诊断标准与关键数值

  • 单参数中70 keV虚拟单能图像鉴别T1期鼻咽癌与淋巴组织增生的AUC最高,为0.92,敏感度80.00%,特异度91.49%。
  • 联合碘浓度、标准化碘浓度、有效原子序数、50 keV、70 keV、90 keV及斜率k的多因素logistic回归模型AUC为0.99,敏感度93.33%,特异度97.87%。

临床应用与阅片要点

  • 作者认为双能CT可有助于鉴别T1期鼻咽癌与淋巴组织增生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the value of dual-energy CT for the differentiation between stage T1 nasopharyngeal carcinoma (NPCT1) and lymphoid hyperplasia (LH).

METHOD: Patients with histopathological proven nasopharyngeal lesions (stage T1 NPCs, n = 30; LHs, n = 47) who underwent dual-energy CT were enrolled in this retrospective study. Quantitative parameters derived from dual-energy CT were measured. Statistical analyses were performed using the independent sample t-test, Wilcoxon rank sum test, and receiver operating characteristic curve (ROC) analysis.

RESULTS: There was significantly higher iodine concentration (IC), normalized iodine concentration (NIC, to internal jugular vein) in NPCT1 compared with LH (p < 0.001). The effective atomic number (Zeff) was significantly higher in NPCT1 than that in LH (p < 0.001). The virtual monochromatic images (VMIs) at 50 keV-110 keV (20 keV-interval) of NPCT1 were all significantly higher than those of LH (all p <0.001). The slope (k) value of spectral attenuation curve was also significantly higher in NPCT1 than LH (p < 0.001). There was no significant difference in virtual noncontrast (VNC) and 130 keV-190 keV (20 keV-interval) between the NPCT1 and LH. For discriminating NPCT1 from LH, the area under curve (AUC) using 70 keV was the highest in all single parameter (AUC, 0.92; sensitivity, 80.00 %; specificity, 91.49 %). Combined multiple parameters (IC, NIC, Zeff, 50 keV, 70 keV, 90 keV, slope (k)) by performing multivariate logistic regression model significantly improve the diagnostic capability in differentiating these two entities, with AUC, sensitivity, and specificity values of 0.99, 93.33 %, 97.87 %, respectively.

CONCLUSIONS: Dual-energy CT can be helpful for the differentiation between NPCT1 and LH lesions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang P, Xiao Z, Tang Z, et al. Dual-energy CT in the differentiation of stage T1 nasopharyngeal carcinoma and lymphoid hyperplasia. Eur J Radiol. 2020. PMID: 31954331. doi:10.1016/j.ejrad.2020.108824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。